Department of Oral and Maxillofacial Pathology, School of Dental Medicine, Tufts University, Boston, MA 02111-1527, USA.
Oral Dis. 2010 Mar;16(2):151-5. doi: 10.1111/j.1601-0825.2009.01606.x. Epub 2009 Aug 3.
To develop a novel test for chronic ulcerative stomatitis (CUS), a chronic immunologically mediated condition that produces oral ulcerations. Current diagnostic methods require expensive and technically demanding in situ immunofluorescence (IF) studies.
An Enzyme-Linked ImmunoSorbent Assay (ELISA) was prepared and tested with serum samples from patients with CUS and negative controls.
The N-terminal portion of the CUS autoantigen, DeltaNp63alpha, was produced as a purified recombinant protein and used to coat ELISA plates. Sera from 25 patients with CUS and 16 negative controls were analyzed for reactive antibodies. The optimal cut-offs for positive and negative samples were determined.
The optimal cut-off of 0.236 resulted in a sensitivity and specificity of the ELISA of 0.80 and 0.75, respectively (exact 95% confidence intervals, P-value of <0.001).
The ELISA developed in this study provides a novel and reliable diagnostic assessment to distinguish CUS from other oral ulcerative diseases.
Immunoassay will allow the true incidence and prevalence of CUS to be determined in future studies. When combined with clinical correlations, the ELISA results will facilitate the evaluation of the prognostic utility of antibody titers and allow correlation with treatment responses in individual CUS cases.
开发一种新的慢性溃疡性口炎(CUS)检测方法,CUS 是一种慢性免疫介导性疾病,会导致口腔溃疡。目前的诊断方法需要昂贵且技术要求高的原位免疫荧光(IF)研究。
制备了一种酶联免疫吸附试验(ELISA),并使用 CUS 患者和阴性对照的血清样本进行了测试。
将 CUS 自身抗原的 N 端部分 DeltaNp63alpha 制成纯化重组蛋白,并用于包被 ELISA 板。分析了 25 例 CUS 患者和 16 例阴性对照的血清中是否存在反应性抗体。确定了阳性和阴性样本的最佳截止值。
最佳截止值为 0.236,ELISA 的灵敏度和特异性分别为 0.80 和 0.75(确切的 95%置信区间,P 值<0.001)。
本研究开发的 ELISA 提供了一种新颖且可靠的诊断评估方法,可用于将 CUS 与其他口腔溃疡性疾病区分开来。
免疫测定将允许在未来的研究中确定 CUS 的真实发病率和患病率。与临床相关性相结合,ELISA 结果将有助于评估抗体滴度的预后效用,并允许在个别 CUS 病例中与治疗反应相关联。